BG27542A3 - Метод за получаване на 1-бензазолилалкил-4-заместени пиперидини - Google Patents

Метод за получаване на 1-бензазолилалкил-4-заместени пиперидини

Info

Publication number
BG27542A3
BG27542A3 BG034394A BG3439476A BG27542A3 BG 27542 A3 BG27542 A3 BG 27542A3 BG 034394 A BG034394 A BG 034394A BG 3439476 A BG3439476 A BG 3439476A BG 27542 A3 BG27542 A3 BG 27542A3
Authority
BG
Bulgaria
Prior art keywords
benzazolylalkyl
preparation
substituted piperidines
piperidines
substituted
Prior art date
Application number
BG034394A
Other languages
Bulgarian (bg)
English (en)
Inventor
Jan Vendenberk
Ludo Kennis
Marcel Vander
Albert Vanheertum
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG27542A3 publication Critical patent/BG27542A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BG034394A 1975-10-08 1976-10-08 Метод за получаване на 1-бензазолилалкил-4-заместени пиперидини BG27542A3 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62072775A 1975-10-08 1975-10-08
US05/713,309 US4035369A (en) 1975-10-08 1976-08-10 1-Benzazolylalkyl-4-substituted-piperidines

Publications (1)

Publication Number Publication Date
BG27542A3 true BG27542A3 (bg) 1979-11-12

Family

ID=27088773

Family Applications (1)

Application Number Title Priority Date Filing Date
BG034394A BG27542A3 (bg) 1975-10-08 1976-10-08 Метод за получаване на 1-бензазолилалкил-4-заместени пиперидини

Country Status (31)

Country Link
US (1) US4035369A (es)
JP (1) JPS5246082A (es)
AT (1) AT365185B (es)
AU (1) AU511834B2 (es)
BG (1) BG27542A3 (es)
CA (1) CA1085853A (es)
CH (1) CH630915A5 (es)
CS (1) CS225101B2 (es)
DE (1) DE2645125A1 (es)
DK (1) DK151801C (es)
EG (1) EG12969A (es)
ES (1) ES452200A1 (es)
FI (1) FI63228C (es)
FR (1) FR2346009A1 (es)
GB (1) GB1532546A (es)
GR (1) GR61672B (es)
HU (1) HU174927B (es)
IE (1) IE43951B1 (es)
IL (1) IL50631A (es)
IT (1) IT1069293B (es)
LU (1) LU75954A1 (es)
NL (1) NL7611085A (es)
NO (1) NO144926C (es)
NZ (1) NZ182134A (es)
PH (1) PH15417A (es)
PL (1) PL106815B1 (es)
PT (1) PT65688B (es)
RO (1) RO69904A (es)
SE (1) SE417610B (es)
SU (1) SU663306A3 (es)
YU (1) YU39976B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
IE810250L (en) * 1980-02-11 1981-08-11 Berlex Lab N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
DE3442757A1 (de) * 1984-11-23 1986-05-28 Wella Ag, 6100 Darmstadt Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
FR2702214B1 (fr) * 1993-03-05 1995-04-14 Adir Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
DE69531476T2 (de) 1994-09-12 2004-06-09 Lilly Industries Ltd., Basingstoke Serotonergische Modulatoren
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
GB9613423D0 (en) * 1996-06-26 1996-08-28 Lilly Industries Ltd Pharmaceutical compounds
JP2010503722A (ja) * 2006-09-19 2010-02-04 シプラ・リミテッド シクレソニドとその結晶変異体の調製方法
CN101759693B (zh) * 2008-12-23 2011-09-14 江苏恩华药业股份有限公司 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用
CA3211341A1 (en) * 2021-03-19 2022-09-22 Centre National De La Recherche Scientifique Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (es) * 1962-06-13
US3225052A (en) * 1964-05-06 1965-12-21 Janssen Pharmaceutica Nv Benzimidazolinyl piperidine derivatives
FR1573739A (es) 1968-07-26 1969-07-04
US3647790A (en) * 1969-04-08 1972-03-07 American Home Prod Ouinoxalinyl-oxazolidines and -oxazines

Also Published As

Publication number Publication date
NZ182134A (en) 1979-01-11
PT65688A (en) 1976-11-01
ATA745276A (de) 1981-05-15
DK151801C (da) 1988-06-06
YU248076A (en) 1983-01-21
AU511834B2 (en) 1980-09-11
DE2645125C2 (es) 1988-11-24
SE7611137L (sv) 1977-04-09
YU39976B (en) 1985-06-30
FR2346009B1 (es) 1978-12-22
IT1069293B (it) 1985-03-25
DK151801B (da) 1988-01-04
NO144926C (no) 1981-12-09
FI762865A (es) 1977-04-09
IL50631A0 (en) 1976-12-31
LU75954A1 (es) 1977-05-09
JPS5246082A (en) 1977-04-12
NO763424L (es) 1977-04-13
RO69904A (fr) 1980-08-15
EG12969A (en) 1981-03-31
HU174927B (hu) 1980-04-28
FR2346009A1 (fr) 1977-10-28
CS225101B2 (en) 1984-02-13
FI63228B (fi) 1983-01-31
IL50631A (en) 1980-02-29
IE43951L (en) 1977-04-08
GR61672B (en) 1978-12-05
NO144926B (no) 1981-08-31
NL7611085A (nl) 1977-04-13
JPS6215553B2 (es) 1987-04-08
ES452200A1 (es) 1978-01-16
FI63228C (fi) 1983-05-10
DE2645125A1 (de) 1977-04-21
DK452076A (da) 1977-04-09
PL192890A1 (pl) 1978-03-28
SE417610B (sv) 1981-03-30
SU663306A3 (ru) 1979-05-15
AU1807876A (en) 1978-04-06
PL106815B1 (pl) 1980-01-31
IE43951B1 (en) 1981-07-01
CH630915A5 (de) 1982-07-15
PH15417A (en) 1983-01-07
AT365185B (de) 1981-12-28
GB1532546A (en) 1978-11-15
CA1085853A (en) 1980-09-16
US4035369A (en) 1977-07-12
PT65688B (en) 1978-04-02

Similar Documents

Publication Publication Date Title
BG26192A3 (bg) Метод за получаване на 3-арилокси-3-фенилпропиламини
TR19292A (tr) Olifinlerin polimerizasyonuna mahsus usul
BG26518A3 (bg) Метод за получаване на производни на фенил-алкан
BG27542A3 (bg) Метод за получаване на 1-бензазолилалкил-4-заместени пиперидини
BG26526A3 (bg) Метод за получаване на 1-(бензазолилалкил)пиперидинови производни
PL193761A1 (pl) Sposob wytwarzania czteropierscieniowych chinonow
BG24539A3 (bg) Метод за получаване на 1-етил- за- субституирани - фенил - декахидроизохинолини
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE408126B (sv) Berband for blixtlas
TR19184A (tr) Usul
IT1069076B (it) Procedimento per produrre triclorometil trifluorometilbenzoli
PL192020A1 (pl) Sposob wytwarzania n-tetrahydrofurfurylo-noroksymorfonow
PL193861A1 (pl) Sposob wytwarzania alfa-aminoketonow
SE411166B (sv) Berband for blixtlas
IT1066655B (it) Procedimento per depurare caprolattame
RO69281A (ro) Procedeu pentru prepararea alchilamino-s-triazinelor
BG26535A3 (bg) Метод за получаване на индолхинолизини
IT1069085B (it) Procedimento per produrre triclorometil-trifluorometil-benzoli
IT1066658B (it) Procedimento per produrre azodicarbossammide
IT1068946B (it) Procedimento per prepararae triemtilidrochinone
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
IT1066001B (it) Procedimento per l esterificazione di clorosilani
BG26534A4 (bg) Метод за получаване на 2-метил-2-цианометил-5- изопропилтетрахидрофуран
PL100145B1 (pl) Sposob wytwarzania nowych zwiazkow dwuureidowych
SE415175B (sv) Forfarande for framstellning av klorcyan